Anti-Spasmogenic Effects of Bencianol (ZY15051 on Human Cerebral Arteries In Vitro

Abstract

Experiments were performed to assess the ability of bencianol (ZY15051) to reverse contractions of human basilar arteries in vitro that were induced by a wide range of substances implicated in the aetiology of migraine and cerebral arterial spasm. Bencianol caused a dose-related (1–100 μg ml^-1) reversal of contractions induced by 5-hydroxytryptamine, nor-adrenaline, angiotensin II, prostaglandin F_2a, and U-46619 (a thromboxane-A₂ mimetic). Bencianol was more effective against contractions induced by EC50 compared to maximal concentrations of each agent, and was least effective against the thromboxane-A₂ mimetic, U-46619. In addition, contractions induced by thromboxane-A₂-like substances generated from guinea-pig lungs were also reversed by bencianol but only at the highest concentration used (100 mg ml^-1). The relevance of this action of bencianol to migraine and cerebral arterial spasm is discussed.

Keywords

Bencianol cerebral arterial spasm flavenoids human basilar artery migraine

Get full access to this article

View all access options for this article.

References

Zervas

NT.

Vasospasm: an update.Clin Neurosurg 1979;26:643–56.

Allen

Gold

LHA

Chou

French

LA.

Cerebral arterial spasm. Part 3: In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenyoxybenzamine.J Neurosurg 1974;40:451–8.

Raynor

McMurtry

Pool

JL.

Cerebrovascular effects of topically applied serotonin in the cat.Neurology 1961;11:190–5.

La Torre

Patrono

Fortuna

Grossi-Belloni

Role of prostaglandin F_2a in human cerebral vasospasm.J Neurosurg 1974;41:293–9.

Elliss

Nies

Oates

JA.

Cerebral arterial smooth muscle contraction by thromboxane A₂ .Stroke 1977;8:480–3.

Alksne

Greenhoot

JH.

Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall.J Neurosurg 1974;41:440–5.

Fraser

RAR

Stein

Barrett

RE.

Noradrenergic mediation of experimental cerebrovascular spasm.Stroke 1970;1:356–62.

Kapp

Mahaley

Odom

GL.

Cerebral arterial spasm. Part 2: Experimental evaluation of mechanical and humoral factors in pathogenesis.J Neurosurg 1968;29:339–49.

Camfield

Metrakos

Andermann

Basilar migraine, seizures, and severe epileptiform EEG abnormalities. A relatively benign syndrome in adolescents.Neurology 1978;28:584–8.

10.

Boullin

DJ.

Cerebral vasospasm-is it a common disorder? In Boullin

edCerebral vasospasm.John Wiley & Son,1980:37–46.

11.

11. Voelter

Jung

eds.O-(b-hydroxyethyl)-rutoside- Experimentelle und Klinische Ergebnisse.Berlin:Springer-Verlag,1978.

12.

Nordmann

Dumont

J-M

Sharma

Gulati

OP.

Beneficial effects of Bencianol (ZY15051) in acute venous stasis edema in rats. Proc IUPHAR 9th Int Cong Pharmacol,1984,650P.

13.

Felix

Backhaus

Eichler

Hennings

Protective and curative effect of O-(b-hydroxyethyl)-rutosides against injury of isolated portal veins caused by polidocanol and ethacrynic acid.Proc Int Bioflavenoid Symp,Munich,F.R.G.1981:501–11.

14.

Jongebreur

Relation between the chemical constitution and the pharmacological action, especially on the coronary vessels of the heart of some synthesised pyrones and khellin.Arch Int Pharmacodyn Ther 1952;90:384–411.

15.

Bundy

GL.

The synthesis of prostaglandin endoperoxide analogues.Tet Lett 1975;24:1957–60.

16.

Coleman

Humphrey

PPA

Kennedy

Levy

Lumley

Comparison of the actions of U-46619, a prostaglandin H₂-analogue with those of prostaglandin H₂ and thromboxane A₂ on some isolated smooth muscle preparations.Br J Pharmacol 1981;73:773–8.

17.

Coleman

Kennedy

Sheldrick

RLG.

A simple method for generating thromboxane A₂..Br J Pharmacol 1980;69:341P–2P.

18.

Paul

Whalley

Forster

Lye

Dutton

Prostacyclin and cerebral vessel relaxation.J Neurosurg 1982;57:334–40.

19.

Gulati

Ponard

Nordmann

Inhibitory effects of Bencianol (ZY15051) on noradrenaline induced constrictions in rat mesentery in vitro and in situ. Proc 3rd World Congr Microcirculation. Oxford1984.

20.

Beretz

Stierle

Anton

Cazenave

J-P.

Role of cyclic-AMP in the inhibition of human platelet aggregation by Quercetin, a flavenoid that potentiates the effect of prostacyclin.Biochem Pharmacol 1981;31:3597–600.

21.

Ruckstuhl

Beretz

Anton

Landry

Flavenoids are selective cyclic GMP phosphodiesterase inhibitors.Biochem Pharmacol 1979;28:535–8.

22.

Ferrell

Chang Sing

PDG

Loew

King

Mansour

TE.

Structure-activity studies of flavenoids as inhibitors of cyclic-AMP, phosphodiesterase and relationship to quantum chemical indices.Mol Pharmacol 1979;16:556–68.